Nerivio
Acute Treatment of Migraine
Key Facts
About Theranica
Theranica is a commercial-stage digital therapeutics company pioneering remote electrical neuromodulation (REN) for migraine. Its FDA-authorized and CE-marked Nerivio device is a prescription wearable for acute migraine treatment in adolescents and adults, offering a drug-free alternative. The company is expanding its technology platform into other neurological conditions, such as chronic migraine prevention and other pain disorders. Backed by venture capital, Theranica operates as a private entity, commercializing its device in the US and internationally.
View full company profileAbout Theranica
Theranica is a commercial-stage digital therapeutics company pioneering remote electrical neuromodulation (REN) for migraine. Its FDA-authorized and CE-marked Nerivio device is a prescription wearable for acute migraine treatment in adolescents and adults, offering a drug-free alternative. The company is expanding its technology platform into other neurological conditions, such as chronic migraine prevention and other pain disorders. Backed by venture capital, Theranica operates as a private entity, commercializing its device in the US and internationally.
View full company profileOther Acute Treatment of Migraine Drugs
| Drug | Company | Phase |
|---|---|---|
| Elismetrep (K-304) | Kallyope | Phase 2 |
| RizaFilm® (RizaPort®) | Gensco Pharma | Approved/Pre-launch |
| ONZETRA Xsail | Currax Pharmaceuticals | Approved |
| TREXIMET | Currax Pharmaceuticals | Approved |
| NVI-100 | Nuvie Bio | Phase 1 |
| gammaCore | electroCore | Commercial |